Pfizer: Pfizer’s vaccine and pill, will end the corona epidemic. 1 News Track English

Pfizer: It seems that the end of the corona epidemic is near and the main weapons are becoming the Pfizer vaccine and one of its tablets (pfizer medicine). Pfizer has announced that it has made a medicine to treat corona infection. The company is confident that with this pill it will be possible to end the epidemic and corona will remain a minor disease.

Pfizer has earned a lot from the Corona vaccine (Pfizer COVID vaccine). Its corona earnings this year are expected to be $ 36 billion, which is 7 percent more than last year. The company will make 4 billion doses in 2022. Now next year, the corona pill will also be added to the vaccine in Pfizer’s quiver. The company has said that taking this pill within three days of symptoms of corona does not lead to hospitalization. Pfizer company has said that this drug is very effective in preventing the serious disease of corona.

Merck company has also made a medicine for the treatment of corona. But Pfizer’s medicine is said to be more effective. Merck’s drug is yet to get FDA approval, Pfizer’s corona antiviral pill has been named ‘Paxlovid’. Taking this pill within three days of seeing a corona infection reduces the risk of hospitalization or death by 89 percent.

Pfizer has said that independent experts overseeing clinical trials of this drug have recommended that the trial should be stopped now because the drug’s effect on patients has proved to be very good. Pfizer has said that it will submit data related to this drug to the FDA very soon so that the drug can be approved for use in the US.

Paxlovid Wiki

According to Analiza Anderson, lead scientist for the development of Paxlovid, the results of this drug have been better than our expectations. He expressed the hope that with PaxLovid, there is hope for all of us to return to normal life and end the corona epidemic.

PaxLovid treatment is likely to be accessible to all in the next few months. In the beginning the supply may be less but it will pick up soon. The drugs from Pfizer and Merck are focused on patients who are at high risk. Such as people above 60 years of age or obese who are at risk of serious corona disease.